FORM 10-Q

                               UNITED STATES

                    SECURITIES AND EXCHANGE COMMISSION

                          WASHINGTON, D.C.  20549

[X]QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
   THE SECURITIES EXCHANGE ACT OF 1934

For Quarterly period ended    June 30, 1997                      
                          --------------------------------------
                                    OR

[ ]TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
   THE SECURITIES EXCHANGE ACT OF 1934

For The transition period from                 to                 
                              ----------------    ----------------
Commission file number     1-7677                                 
                      --------------------------------------------          

                            LSB INDUSTRIES, INC.               
           ----------------------------------------------------
           Exact name of Registrant as specified in its charter 


         DELAWARE                           73-1015226       
- ------------------------------            ---------------
State or other jurisdiction of            I.R.S. Employer 
incorporation or organization             Identification No.

          16 South Pennsylvania,   Oklahoma City, Oklahoma  73107
          -------------------------------------------------------
            Address of principal executive offices    (Zip Code)

                               (405) 235-4546                     
            --------------------------------------------------
            Registrant's telephone number, including area code 

                                   None                            
            ----------------------------------------------------
            Former name, former address and former fiscal year, if 
                           changed since last report. 

  Indicate by check mark whether the Registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such
shorter period that the Registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90
days.
                    YES   x        NO    
                       ------         ------
The number of shares outstanding of the Registrant's voting Common
Stock, as of August 12, 1997 is 12,861,081 shares excluding 2,152,395
shares held as treasury stock.


                                  PART I

                           FINANCIAL INFORMATION


Company or group of companies for which report is filed:  LSB
Industries, Inc. and all of its wholly-owned subsidiaries.

The accompanying condensed consolidated balance sheet of LSB
Industries, Inc., at June 30, 1997, the condensed consolidated 
statements of operations for the six month and three month
periods ended June 30, 1997 and 1996 and the consolidated
statements of cash flows for the six month periods ended June 30,
1997 and 1996 are unaudited and reflect all adjustments,
consisting primarily of adjustments of a normal recurring nature,
which are, in the opinion of management, necessary for a fair
presentation of the interim periods.  The results of operations
for the six months and three months ended June 30, 1997 are not
necessarily indicative of the results to be expected for the full
year.  The condensed consolidated balance sheet at December 31,
1996, was derived from audited financial statements as of that
date.


                           LSB INDUSTRIES, INC.
                   CONDENSED CONSOLIDATED BALANCE SHEETS
                (Information at June 30, 1997 is unaudited)
                          (Dollars in thousands)

                                                     June 30,    December 31, 
ASSETS                                                 1997         1996
_______________________________________             ___________   __________

Current assets:

  Cash and cash equivalents                          $     769   $    1,620

  Trade accounts receivable, net of allowance           56,578       50,791

  Inventories:
    Finished goods                                      37,720       36,304
    Work in process                                      6,490       12,084
    Raw materials                                       19,232       19,594
                                                   ___________   __________
      Total inventory                                   63,442       67,982

  Supplies and prepaid items                             7,978        7,217
                                                   ___________   __________
    Total current assets                               128,767      127,610

Property, plant and equipment, net                     119,547      103,143

Investments and other assets:

  Loans receivable, secured by real estate                 743       15,010
  
  Other assets, net of allowance                        17,163       15,521
                                                   ___________   __________
                                                    $  266,220   $  261,284
                                                                      



                         (Continued on following page)





                              LSB INDUSTRIES, INC.
                     CONDENSED CONSOLIDATED BALANCE SHEETS
                                  (Continued)
                  (Information at June 30, 1997 is unaudited)
                             (Dollars in thousands)

                                                     June 30,   December 31,
LIABILITIES    AND STOCKHOLDERS' EQUITY                1997         1996
____________________________________               ___________   __________
Current liabilities:
  Drafts payable                                    $      519   $      536
  Accounts payable                                      35,715       41,796
  Accrued liabilities                                   12,385       12,780
  Current portion of long-term debt (Note 1)            14,904       13,007
                                                   ___________   __________
     Total current liabilities                          63,523       68,119

Long-term debt (Note 1)                                135,135      119,277

Contingencies (Note 5)

Redeemable, noncumulative convertible
  preferred stock, $100 par value; 1,539 shares
  issued and outstanding                                   146          146

Stockholders' equity (Note 4):
  Series B 12% cumulative, convertible
    preferred stock, $100 par value;
    20,000 shares issued and outstanding                 2,000        2,000
  Series 2 $3.25 convertible, exchangeable
    Class C preferred stock, $50 stated
    value; 920,000 shares issued                        46,000       46,000
  Common stock, $.10 par value; 75,000,000
    shares authorized, 15,013,476 shares
    issued (14,888,476 in 1996)                          1,501        1,489
  Capital in excess of par value                        38,227       37,843
  Accumulated deficit                                   (8,687)      (2,706)
                                                   ___________   __________
                                                        79,041       84,626
Less treasury stock, at cost:
  Series 2 Preferred, 5,000 shares                         200          200
  Common stock, 2,079,395 shares 
  (1,913,120 in 1996)                                   11,425       10,684
                                                   ___________   __________
    Total stockholders' equity                          67,416       73,742
                                                   ___________   __________
                                                    $  266,220   $  261,284
                                                   ===========   ==========

                            (See accompanying notes)
                                        


                             LSB INDUSTRIES, INC. 
                CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                  (Unaudited)
                    Six Months Ended June 30, 1997 and 1996
                (Dollars in thousands, except per share amounts)

                                                       1997         1996
                                                    __________   __________
Revenues:
  Net sales                                          $ 162,502   $  159,375
  Other income                                           3,801        2,991    
                                                    __________   __________
                                                       166,303      162,366
Costs and expenses:
  Cost of sales                                        132,199      127,335 
  Selling, general and administrative                   31,554       27,087
  Interest                                               6,396        5,964
                                                    __________   __________
                                                       170,149      160,386
                                                    __________   __________
Income (loss) before provision for
  income taxes                                          (3,846)       1,980
Provision for income taxes                                  125         139
                                                    -----------  ----------
Net income (loss)                                    $   (3,971) $    1,841
                                                    ===========  ==========
Net income (loss) applicable to 
  common stock (Note 3)                              $   (5,594) $      218
                                                    ===========  ==========
Average common shares outstanding (Note 3):
  Primary                                            13,066,250  13,129,970

  Fully diluted                                      13,068,250  13,465,303

Earnings (loss) per common share (Note 3):
  Primary                                            $     (.43) $      .02 
                                                     ==========  ==========
  Fully diluted                                      $     (.43) $      .02
                                                     ==========  ==========

                            (See accompanying notes)



                             LSB INDUSTRIES, INC. 
                CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                  (Unaudited)
                   Three Months Ended June 30, 1997 and 1996
                (Dollars in thousands, except per share amounts)

                                                       1997          1996
                                                    __________   __________
Revenues:
  Net sales                                          $  89,268   $   89,880
  Other income                                           2,171        1,580    
                                                    __________   __________
                                                        91,439       91,460
Costs and expenses:
  Cost of sales                                         69,887       72,647 
  Selling, general and administrative                   16,682       13,369
  Interest                                               3,340        2,995
                                                    __________   __________
                                                        89,909       89,011
                                                    __________   __________
Income before provision for
  income taxes                                           1,530        2,449
Provision for income taxes                                  63           77
                                                    ----------   ----------
Net income                                          $    1,467   $    2,372
                                                    ==========   ==========
Net income applicable to 
  common stock (Note 3)                             $      648   $    1,568
                                                    ==========   ==========
Average common shares outstanding (Note 3):
  Primary                                           13,157,676   13,348,553

  Fully diluted                                     13,161,676   14,019,219

Earnings per common share (Note 3):
  Primary                                           $      .05   $      .12 
                                                    ==========   ==========
  Fully diluted                                     $      .05   $      .12
                                                    ==========   ==========

                            (See accompanying notes)



                              LSB INDUSTRIES, INC.
                CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                  (Unaudited)
                    Six Months Ended June 30, 1997 and 1996
                             (Dollars in thousands)

                                                      1997         1996
                                                   ___________  __________
Cash flows from operations:           
  Net income (loss)                                  $  (3,971)  $    1,841
  Adjustments to reconcile net income (loss)
    to cash flows provided (used) by operations:        
      Depreciation, depletion and amortization:
       Property, plant and equipment                     5,141        4,522
       Other                                               567          617 
     Provision for possible losses                              
       on receivables and other assets                   1,066          677
     Loss (gain) on sale of assets                           9         (767)
     Recapture of prior period provisions for loss
        on loans receivable secured by real estate      (1,383)           - 
      Cash provided (used) by changes in assets
       and liabilities:
         Trade accounts receivable                     ( 5,834)     (17,959)
         Inventories                                     4,540        1,169  
         Supplies and prepaid items                     (  716)      (1,880)
         Accounts payable                               (6,081)      23,372 
         Accrued liabilities                              (853)         598 
                                                   ___________    _________
     Net cash provided (used) by operations             (7,515)      12,190 

Cash flows from investing activities:  
    Capital expenditures                                (5,701)      (7,381)
    Principal payments on notes receivable                 203           75
    Proceeds from sales of equipment and
     real estate properties                                360          236
    Proceeds from sale of investment securities              -        1,444
    Increase in other assets                            (2,994)        (985)
                                                    ----------    ---------
    Net cash used in investing activities               (8,132)      (6,611)

Cash flows from financing activities:  
    Payments on long-term and other debt               (23,041)      (3,365)
    Long-term and other borrowings                      53,864        5,647
    Net change in revolving debt                       (13,655)      (3,465)
    Net change in drafts payable                           (17)       (424)
    Dividends paid (Note 4):                          
      Preferred stocks                                  (1,621)      (1,623)
      Common Stock                                        (389)        (389)
    Purchases of treasury stock (Note 4)                  (535)         (12)
    Net proceeds from issuance of common stock             190            - 
                                                     _________   __________

    Net cash provided (used) by financing activities    14,796       (3,631)
                                                     _________   __________
Net increase (decrease) in cash                           (851)       1,948 

Cash and cash equivalents at beginning of period         1,620        1,420     
                                                     ---------   ----------
Cash and cash equivalents at end of period           $     769   $    3,368
                                                     =========   ==========

                            (See accompanying notes)

Note 1:  The Company's working capital line of credit has a
scheduled termination date of April 1, 1998, and as of June 30,
1997, the Company was not in compliance with its financial
covenants relating to Tangible Net Worth and Debt-to-Worth.  The
Company's working capital lender has waived such defaults as of
June 30, 1997.  As of the date of this report, the lender has
verbally committed to an extension of the termination date so
that the termination date will be scheduled to occur more than
twelve months from June 30, 1997, and resetting the Company's
Tangible Net Worth and Debt-to-Worth financial covenants so that
such are consistent with the Company's current projections for
the next twelve months.  Accordingly, the Company has classified
the $43.4 million due under the working capital line of credit at
June 30, 1997 as long-term debt due after one year in the
accompanying condensed consolidated financial statements.  As of
the date of this report, there are no assurances that the lender
will extend the scheduled termination date and reset the Tangible
Net Worth and Debt-to-Worth financial covenants and, if such
financial covenants are reset, that the Company will be able to
comply with such reset covenants.

Note 2:  At June 30, 1997, the Company had net operating loss
("NOL") carryforwards for tax purposes of approximately $45
million (approximately $10 million alternative minimum tax NOLs). 
Such amounts of regular tax NOL expire beginning in 1999.  The
Company also has investment tax credit carryforwards of
approximately $356,000 which begin expiring in 1997.

The Company s provision for income taxes for the six months ended
June 30, 1997 of $125,000 is for current state income taxes and
federal alternative minimum tax.

Note 3:  Primary earnings per common share are based upon the
weighted average number of common shares and dilutive common
equivalent shares outstanding during each period, after giving
appropriate effect to preferred stock dividends.  

Fully diluted earnings per share are based on the weighted
average number of common shares and dilutive common equivalent
shares outstanding and the assumed conversion of dilutive
convertible securities outstanding after appropriate adjustment
for interest and related income tax effects on convertible notes
payable.

Net income applicable to common stock is computed by adjusting
net income by the amount of preferred stock dividends, including
undeclared or unpaid dividends, if cumulative.

In February 1997, the Financial Accounting Standards Board issued
statement No. 128, Earnings per Share, which is required to be
adopted on December 31, 1997.  At that time, the Company will be
required to change the method currently used to compute earnings
per share and to restate all prior periods.  Under the new
requirements for calculating primary earnings per share, the
dilutive effect of stock options will be excluded.  Based on the
Company's review of its earnings per share calculation,  the
impact of Statement No. 128 on both primary and fully diluted
earnings per share for the periods presented herein are not
expected to be material.

Note 4:  The table below provides detail of activity in the Stockholders' 
equity accounts for the six months ended June 30, 1997:



                              Common Stock    Non-     Capital                   Treasury
                             _______________  redeemable   in excess         Treasury     Stock
                                        Par    Preferred     of par  Accumulated Stock-    Prefer-
                             Shares    Value     Stock       Value    Deficit    Common     red     Total
                             ______   ______   _________   ________   ________  ________  _______  _______
                                                 (In thousands)
                                                                            
Balance at December 31, 1996 14,888  $ 1,489   $ 48,000    $ 37,843   $(2,706)  $(10,684)  $ (200)  $73,742 
Net loss                                                               (3,971)                       (3,971)
Exercise of stock options:
  Cash received                  61        6                    184                                     190 
  Stock tendered and added 
    to treasury at market value  64        6                    200                 (206)                 
Dividends declared:
  Common Stock ($.03 per share)                                          (389)                         (389)
  Series B 12% preferred 
    stock ($6.00 per share)                                              (120)                         (120)
  Redeemable preferred 
    stock ($10.00 per share)                                              (16)                          (16)
  Series 2 preferred
    stock ($1.62 per share)                                            (1,485)                       (1,485)
Purchase of treasury stock                                                          (535)              (535)
                             ______  _______   ________    ________   _______   ________   ______   _______
                                (1)       
Balance at June 30, 1997     15,013  $ 1,501   $ 48,000    $ 38,227   $(8,687)  $(11,425)  $ (200)  $67,416 
                             ======  =======   ========    ========   =======   ========   ======   ======= 



     (1)    
     Includes 2,079,395 shares of the Company's Common Stock held in treasury.  
Excluding the 2,079,395 shares held in treasury, the outstanding 
shares of the Company's Common Stock at June 30, 1997 were 12,934,081.

Note 5:  Following is a summary of certain legal actions
involving the Company:

A.   In 1987, the U.S. Government notified one of the Company's
     subsidiaries along with numerous other companies, of
     potential responsibility for clean-up of a waste disposal
     site in Oklahoma.  No legal action has yet been filed.  The
     amount of the Company's cost associated with the clean-up of
     the site is unknown. Accordingly, no provision for any
     liability which may result has been made in the accompanying
     financial statements.  
     
B.   The Company submitted to the State of Arkansas a
     "Groundwater Monitoring Work Plan"  which was approved by
     the State of Arkansas.  Pursuant to the Groundwater
     Monitoring Work Plan, the Company has performed phase I and
     II groundwater investigations, and submitted a risk
     assessment report to the State of Arkansas.  The risk
     assessment report is currently being reviewed by the State
     of Arkansas. 
     
     On February 12, 1996, the Company entered into a Consent
     Administrative Agreement ("Administrative Agreement") with
     the state of Arkansas to resolve certain compliance issues
     associated with nitric acid concentrators.  Pursuant to the
     Administrative Agreement, the Company installed additional
     pollution control equipment to address the compliance
     issues.  The Company was assessed $50,000 in civil penalties
     associated with the Administrative Agreement.  In the summer
     of 1996 and then on January 28, 1997, the Company executed
     amendments to the Administrative Agreement ("Amended
     Agreements").  The Amended Agreements imposed a $150,000
     civil penalty, which penalty has been paid.  

C.   In 1996, a lawsuit was filed against the Company's Chemical
     Business by a group of residents of El Dorado, Arkansas,
     asserting a citizens' suit against the Chemical Business as
     a result of certain alleged violations of the Clean Air Act,
     the Clean Water Act, the Chemical Business' air and water
     permits and certain other environmental laws, rules and
     regulations.  The citizens' suit requests the court to order
     the Chemical Business to cure such alleged violations, if
     any, plus penalties as provided under the applicable
     statutes.  The Company's Chemical Business will assert all
     defenses available to it and will vigorously defend itself.

     In July 1996, several of the same individuals who are
     plaintiffs in the citizens' suit referenced above filed a
     toxic tort lawsuit against the Company's Chemical Business
     alleging that they suffered certain injuries and damages as
     a result of alleged releases of toxic substances from the
     Chemical Business' El Dorado, Arkansas manufacturing
     facility.  In October 1996, another toxic tort lawsuit was
     filed against the Company's Chemical Business.  This
     subsequent action asserts similar damage theories as the
     previously discussed lawsuit, except this action attempts to
     have a class certified to represent substantially all
     allegedly affected persons.  The plaintiffs are suing for an
     unspecified amount of actual and punitive damages. 

     The Company's insurance carriers have been notified of these
     matters. The Company and the Chemical Business maintain an
     Environmental Impairment Insurance Policy ("EIL Insurance")
     that provides coverage to the Company and the Chemical
     Business for certain discharges, dispersals, releases, or
     escapes of certain contaminants and pollutants into or upon
     land, the atmosphere or any water course or body of water
     from the Site, which has caused bodily injury, property
     damage or contamination to others or to other property not
     on the Site.  The EIL Insurance provides limits of liability
     for each loss up to $10.0 million and a similar $10.0
     million limit for all losses due to bodily injury or
     property damage, except $5.0 million for all remediation
     expenses, with the maximum limit of liability for all claims
     under the EIL Insurance not to exceed $10.0 million for each
     loss or remediation expense and $10.0 million for all losses
     and remediation expenses.  The EIL Insurance also provides a
     retention of the first $500,000 per loss or remediation
     expense that is to be paid by the Company.  The Company's
     Chemical Business has spent an amount in excess of $500,000
     in legal, expert and other costs in connection with the
     toxic tort and citizen lawsuits described in this paragraph
     C, which the Company expensed and has made a claim against
     its EIL Insurance for reimbursement of the legal, expert and
     other costs paid by the Chemical Business in excess of
     $500,000 and to pay such legal, expert and other costs on an
     on-going basis.  The Company and the EIL Insurance Carrier
     are presently negotiating this claim.  There are no
     assurances that the Company and its EIL Insurance Carrier
     will be able to satisfactorily resolve this matter.

D.   A civil cause of action has been filed against the Company's
     Chemical Business and five (5) other unrelated commercial
     explosives manufacturers alleging that the defendants
     allegedly violated certain federal and state antitrust laws
     in connection with alleged price fixing of certain explosive
     products.  The plaintiffs are suing for an unspecified
     amount of damages, which, pursuant to statute, plaintiffs
     are requesting be trebled, together with costs.  Based on
     the information presently available to the Company, the
     Company does not believe that the Chemical Business
     conspired with any party, including but not limited to, the
     five (5) other defendants, to fix prices in connection with
     the sale of commercial explosives.  Discovery has only
     recently commenced in this matter.  The Chemical Business
     intends to vigorously defend itself in this matter.

     The Company's Chemical Business has been added as a
     defendant in a separate lawsuit pending in Missouri.  This
     lawsuit alleges a national conspiracy, as well as a regional
     conspiracy, directed against explosive customers in Missouri
     and seeks unspecified damages.  The Company's Chemical
     Business has been included in this lawsuit because it sold
     products to customers in Missouri during a time in which
     other defendants have admitted to participating in an
     antitrust conspiracy, and because it has been sued in the
     preceding described lawsuit.  Based on the information
     presently available to the Company, the Company does not
     believe that the Chemical Business conspired with any party,
     to fix prices in connection with the sale of commercial
     explosives.  The Chemical Business intends to vigorously
     defend itself in this matter.

     For several years the explosive industry has been under an
     investigation by the U.S. Department of Justice.  Certain
     explosive companies plead guilty to antitrust violations. 
     In connection with that investigation, the Chemical Business
     received and has complied with certain document subpoenas,
     and certain of the Chemical Business' employees have been
     subpoenaed to testify in connection with such investigation. 
     As of the date of this report, the Chemical Business has not
     been identified as a target of this investigation.

The Company including its subsidiaries, is a party to various
other claims, legal actions, and complaints arising in the
ordinary course of business.  In the opinion of management after
consultation with counsel, all claims, legal actions (including
those described above) and complaints are adequately covered by
insurance, or if not so covered, are without merit or are of such
kind, or involve such amounts that unfavorable disposition would
not have a material effect on the financial position of the
Company, but could have a material impact to the net income
(loss) of a particular quarter or year, if resolved unfavorably.

Debt Guarantee

The Company has guaranteed approximately $2.6 million of
indebtedness of a start-up aviation company, Kestrel Aircraft
Company, in exchange for a 25.6% ownership interest, to which no
value has been assigned as of June 30, 1997.  The Company has
advanced the aviation company $341,000 as of June 30, 1997 and is
accruing losses of the aviation company based on its ownership
percentage.  As a result, the Company has recorded losses of
$1,591,000 ($375,000 in the first six months of 1997, and
$626,000 and $590,000 in the years ended December 31, 1996 and
1995, respectively) related to the debt guarantee.  The debt
guarantee relates to a $2 million term note and up to $600,000 of
a $2 million revolving credit facility.  The $2 million term note
requires interest only payments through September 1998;
thereafter, it requires monthly principal payments of $11,111
plus interest beginning in October 1998 until it matures on
August 8, 1999, at which time all outstanding principal and
unpaid interest are due.  In the event of a default of this note,
the Company would be required to assume payments on the note with
the term extended until August 2004.  The $2 million revolving
credit facility, on which a subsidiary of the Company has
guaranteed up to $600,000 of indebtedness, had a balance of
approximately $1.1 million as of June 30, 1997.

Nitric Acid Project 

In June 1997, El Dorado Chemical Company ("El Dorado"), a wholly-
owned subsidiary of the Company, El Dorado Nitrogen Company
("EDNC"), a wholly-owned subsidiary of El Dorado, and Bayer
Corporation ("Bayer"), a corporation that is a non-affiliate of
the Company, entered into a series of agreements (collectively,
the "Agreement") whereby EDNC will act as agent to build and will
operate a nitric acid plant at Bayer's Baytown, Texas chemical
facility ("Nitric Acid Plant").  Under the terms of the
Agreement, Bayer has agreed to purchase from EDNC their required
amount of nitric acid used or to be used by Bayer at its Baytown,
Texas facility for ten years from the date on which the Nitric
Acid Plant becomes fully operational.  The Agreement provides for
up to six renewal terms of five years each, however, prior to
each renewal period, either party to the Agreement may opt
against renewal.  El Dorado has guaranteed the performance of
EDNC's obligations under the Agreement.

EDNC is to lease the Nitric Acid Plant pursuant to an operating
lease with an initial lease term of ten years from the date on
which the Nitric Acid Plant becomes fully operational.  EDNC has
an option to purchase the Nitric Acid Plant at the end of the
initial 10 year term.  It is anticipated that construction of the
Nitric Acid Plant will cost approximately $60 million and will be
completed by the end of 1998.  If operations at the Nitric Acid
Plant are not commenced by February 1, 1999, Bayer has an option
to terminate the Agreement.  Construction financing of the Nitric
Acid Plant is to be provided by an unaffiliated lender.  Neither
the Company, nor El Dorado, has guaranteed any of the lending
obligations for the Nitric Acid Plant.  The transaction with
Bayer is subject to EDNC as construction agent finalizing a long-
form contract with an unrelated third party to construct the
Nitric Acid Plant, which contract is presently being negotiated. 


 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
  RESULTS OF OPERATIONS

     The following Management's Discussion and Analysis of
Financial Condition and Results of Operations should be read in
conjunction with a review of the Company's June 30, 1997
Condensed Consolidated Financial Statements. 

OVERVIEW

     The Company is pursuing a strategy of focusing on its more
profitable businesses and concentrating on businesses and product
lines in niche markets where the Company has established or can
establish a position as a market leader.  In addition, the
Company is seeking to improve its liquidity and profits through
liquidation of inventory that is on its balance sheet and on
which it is not realizing an acceptable return nor does it have
the potential to do so.

     In this connection, the Company has been concentrating on
reshaping the Automotive Products Business by the liquidation of
certain of their assets that don't have the potential to earn an
acceptable return and focusing on product lines that management
believes have strategic advantages within select niche markets. 
The Company has also recruited new key management people in the
Automotive Products Business including marketing, materials
control, manufacturing, and financial.  The Company continues to
explore its alternatives to accomplish these goals.

     In addition, the Company has been liquidating certain slow
moving inventory in the Industrial Products Business in the
ordinary course of business.  It is the present intention of the
Company to limit this Business to lines of machine tools which
should result in an acceptable return on capital employed.

     Certain statements contained in this Overview are forward-
looking statements, and the results thereof could differ
materially from such statements if the Company is unable to
liquidate such assets in a reasonable period or on reasonable
terms, and if able to liquidate such assets, it may not be able
to improve profits in the Automotive Products Business or have an
acceptable return on capital employed in these Businesses if
general economic conditions deteriorate drastically from the
environment these Businesses currently operate in or these
Businesses are unable to meet competitive pressures in the market
place which restrict these Businesses from manufacturing or
purchasing and selling their products at acceptable prices.


     Information about the Company's continuing operations in
different industry segments for the six months and three months
ended June 30, 1997 and 1996 is detailed below.


                                     Six Months         Three Months 
                                  1997       1996      1997      1996  
                                  ----       ----      ----      ----
                                            (In thousands)   
                                              (Unaudited)    
Sales:   
  Chemical                      $ 90,196  $ 90,118  $ 49,597  $ 53,598 
  Environmental Control           47,822    41,512    26,199    22,517 
  Automotive Products             17,037    20,738     9,045     9,782 
  Industrial Products              7,447     7,007     4,427     3,983 
                                 _______   _______   _______   _______ 
                                $162,502  $159,375  $ 89,268  $ 89,880 
                                 =======   =======   =======   ======= 
Gross profit:
  Chemical                      $ 12,783  $ 16,116  $  9,399  $  9,316 
  Environmental Control           13,683    10,255     7,675     5,556 
  Automotive Products              2,226     4,005     1,117     1,555 
  Industrial Products              1,611     1,664     1,190       806 
                                 _______   _______   _______   _______ 
                                $ 30,303  $ 32,040  $ 19,381  $ 17,233 
                                 =======   =======   =======   =======
Operating profit (loss):
  Chemical                      $  4,734  $  9,825  $  5,379  $  6,280 
  Environmental Control            4,391     2,301     2,840     1,580 
  Automotive Products             (2,889)     (690)   (1,663)     (829)
  Industrial Products               (710)   (1,045)      (45)     (548)
                                 _______   _______   _______   _______ 
                                   5,526    10,391     6,511     6,483 
General corporate expenses        (2,976)   (2,447)   (1,641)   (1,039)
Interest expense                  (6,396)   (5,964)   (3,340)   (2,995)
                                 _______   _______   _______   _______ 
Income (loss) before provision 
for income taxes                $ (3,846) $  1,980  $  1,530  $  2,449 
                                 =======   =======   =======   =======

Gross profit by industry segment represents net sales less cost
of sales.  Operating profit by industry segment represents
revenues less operating expenses before deducting general
corporate expenses, interest expense and income taxes.  As
indicated in the above table the operating profit for the first
six months (as defined) declined from $10.4 million in 1996 to
$5.5 million in 1997, while sales increased approximately 2.0%. 
The decline in operating profit, coupled with increases in
general corporate expenses, primarily legal fees, and interest
expense, resulted in a loss before income taxes for the first six
months of 1997 of approximately $3.8 million.  

Chemical Business 

     The operating profit in the Chemical Business is down from
$9.8 million in the first six months of 1996 to $4.7 million in
the first six months of 1997.  During the first quarter of 1997,
the Chemical Business continued to incur significant amounts of
downtime at its El Dorado, Arkansas Plant site due to mechanical
problems being incurred at the plant.  The downtime resulted in
increases in manufacturing overhead and lower absorption of such
costs.  The unabsorbed overhead (partially offset by an insurance
settlement) combined with the continued high cost of the primary
raw material, ammonia, led to higher cost of sales as a percent
of sales and lower gross profit margins.  During the first six
months of 1997, the Company believes that it substantially
completed repairs to resolve the mechanical problems resulting in
substantial downtime experienced during 1996 and the first six
months of 1997 at the El Dorado, Arkansas facility.

     The Chemical Business purchases approximately 250,000 tons
per year of ammonia.  The cost of ammonia consumed by the
Chemical Business in 1996 averaged $167 per ton, while in
November and December 1996, ammonia prices took an unexpected
increase to an average of approximately $200 per ton.  During the
first quarter of 1997, ammonia prices continued to increase
through February (a high of $217 per ton) and then began to
decline during the second quarter so that the price for June,
1997 approximated $167 per ton.  The continued volatility in
ammonia prices had a disruptive effect on the first six months
results of the Chemical Business' operations.  The price of
ammonia averaged $32 more per ton in the first six months of 1997
than in the first six months of 1996.  During the first half of
1997, the Chemical Business entered into agreements with
unrelated suppliers of ammonia to purchase its ammonia
requirements.  Under these agreements the Company believes that
the prices the Chemical Business' will be required to pay for
ammonia will be favorable.  However, there are no assurances that
the pricing pursuant to the above agreements will result in
reduced costs to the Chemical Business since such pricing is
subject to variations due to numerous factors.

     As discussed in Note 5 of Notes to Condensed Consolidated
Financial Statements, the Chemical Business has finalized an
agreement with Bayer Corporation ("Bayer") for the Chemical
Business to act as construction agent to build and will operate a
nitric acid plant located on property owned by Bayer in Baytown,
Texas.  When the transaction is completed, the Chemical Business
will provide nitric acid from such plant to Bayer's Baytown,
Texas plant.  Such nitric acid plant will be leased to the
Chemical Business for a period expected to equal ten years under
an operating lease.  The Chemical Business has an option to
purchase such nitric acid plant at the end of the initial 10 year
term.  It is expected that the cost to construct the nitric acid
plant will be approximately $60 million and that it will be
completed by the end of 1998.  The construction financing is to
be provided by an unrelated lender.  See Note 5 of Notes to
Condensed Consolidated Financial Statements.  

Environmental Control Business

     As indicated in the above table, the Environmental Control
Business reported improved sales (an increase of 15.2%) and
improved operating profit for the first six months of 1997, over
that of the first six months of 1996, primarily as a result of
improved market conditions for the heat pump product lines.

Automotive and Industrial Products Businesses

     As indicated in the above table, during the first six months
of 1997 these Businesses recorded combined sales of $24.5 million
and reported an operating loss (as defined above) of $3.6
million, as compared to combined sales of $27.7 million and an
operating loss of $1.7 million for the first six months of 1996,
as a result of lower sales and decreased absorption of
manufacturing costs due to lower production volume. As a result
of the inventory reduction program put into place in 1995,
inventories of these Businesses decreased approximately $1.0
million during the six months ended June 30, 1997.


RESULTS OF OPERATIONS

Six months ended June 30, 1997 vs. Six months ended June 30,
1996.

     Revenues

     Total revenues for the six months ended June 30, 1997 and
1996 were $166.3 million and $162.4 million, respectively (an
increase of $ 3.9 million). Sales increased $3.1 million.  Other
income increased $.8 million.  In February 1997, the Company
exercised its option to acquire an office building in Oklahoma
City, Oklahoma (the "Tower"), by foreclosing against the balance
owed the Company under a note receivable.  As part of this
transaction, the Company recaptured $1.4 million of prior period
provisions for potential losses on loans receivable secured by
the Tower.  This amount is included in other income in 1997.

     Net Sales

     Consolidated net sales included in total revenues for the
six months ended June 30, 1997 were $162.5 million, compared to   
$159.4 million for the first six months of 1996, an increase of  
$3.1 million.  This increase in sales resulted principally from:
(i) increased sales in the Environmental Control Business of $6.3
million, primarily due to increased heat pump sales; and, (ii)
increased sales of machine tools in the Industrial Products
Business of $.4 million, offset by (iii) decreased sales in the
Automotive Products Business of $3.7 million primarily due to
less units being shipped and product mix. 

     Gross Profit

     Gross profit was 18.6% for the first six months of 1997,
compared to 20.1% for the first six months of 1996.  The decrease
in the gross profit percentage was due primarily to (i) higher
production costs in the Chemical Business due to the effect of
higher prices of ammonia and unabsorbed overhead costs caused by
excessive downtime related to modifications made to resolve
problems associated with mechanical failures at the Chemical
Business' primary manufacturing plant, offset by a reduction in
cost of sales of $1.3 million through recapture of manufacturing
variances of the Chemical Business in the form of a business
interruption insurance settlement, and (ii) decreased absorption
of costs due to lower production volumes in the Automotive
Products Business. 

     Selling, General and Administrative Expense

     Selling, general and administrative ("SG&A") expenses as a
percent of net sales were 19.4% and 17.0% in the six month
periods ended June 30, 1997 and 1996, respectively. 
Approximately $840,000 of this increase is due to the operations
of the Tower in 1997 as discussed elsewhere in this report.  The
remaining increase is primarily the result of increased bad debt
provisions, increased professional fees related to environmental
matters in the Chemical Business and decreased sales volume in
the Automotive Products Business without a corresponding decrease
in SG&A.

     Interest Expense

     Interest expense for the Company, before deducting
capitalized interest, was approximately $7.5 million during the
six months ended June 30, 1997 compared to approximately $6.0
million during the six months ended June 30, 1996.  During the
first six months of 1997, $1.1 million of interest expense was
capitalized in connection with construction of the DSN Plant. 
The 1997 increase of $1.5 million before the effect of
capitalization primarily resulted from increased borrowings.

     Income Before Taxes

     The Company had a loss before income taxes of $3.8 million
in the first six months of 1997 compared to income before income
taxes of $2.0 million in the six months ended June 30, 1996.  The
decreased profitability of $5.8 million was primarily due to the
decline in gross profit, increase in SG&A and increase in
interest expense as previously discussed.

     Provision For Income Taxes

     As a result of the Company's net operating loss carryforward
for income tax purposes as discussed elsewhere herein and in Note
2 of Notes to Condensed Consolidated Financial Statements, the
Company's provisions for income taxes for the six months ended
June 30, 1997 and the six months ended June 30, 1996 are for
current state income taxes and federal alternative minimum taxes.

Three months ended June 30, 1997 vs. Three months ended June 30,
1996.

     Revenues

     Total revenues for the three months ended June 30, 1997 and
1996 were approximately the same. Sales decreased $.6 million. 
Other income increased $.6 million.

     Net Sales

     Consolidated net sales included in total revenues for the
three months ended June 30, 1997 were $89.3 million, compared to
$89.9 million for the second quarter of 1996, a decrease of $.6
million.  This decrease in sales resulted principally from: (i)
increased sales in the Environmental Control Business of $3.7
million, primarily due to firming of market conditions for this
Business' Heat Pump Product lines, and (ii) increased machine
tool sales in the Industrial Products Business of $.4 million,
offset by (iii) decreased sales in the Chemical Business of $4.0
million primarily due to a delayed start of the agricultural
season in April due to wet weather conditions, and (iv) decreased
sales in the Automotive Products Business of $.7 million.

     Gross Profit

     Gross profit was 21.7% for the second quarter of 1997,
compared to 19.2% for the second quarter of 1996.  The
improvement in the gross profit percentage was due primarily to
(i) higher prices and increased absorption of costs due to higher
production volumes in the Environmental Control Business, and
(ii) the settlement of a $1.3 million business interruption
insurance claim in the second quarter of 1997 which reduced cost
of sales in the Chemical Business. 

     Selling, General and Administrative Expense

     Selling, general and administrative ("SG&A") expenses as a
percent of net sales were 18.7% and 14.9% in the three month
periods ended June 30, 1997 and 1996, respectively. 
Approximately $840,000 of this increase is due to the operations
of the Tower in 1997 as discussed elsewhere in this report.  The
remaining increase is primarily the result of increased
professional fees related to litigation matters as discussed in
Note 5 of Notes to Condensed Consolidated Financial Statements
and increased bad debt provisions compounded by lower sales in
the Chemical and Automotive Products Businesses.   

     Interest Expense

     Interest expense for the Company, before deducting
capitalized interest, was approximately $3.8 million during the
three months ended June 30, 1997 compared to approximately $3.0
million during the three months ended June 30, 1996.  During the
second quarter of 1997, $.4 million of interest expense was
capitalized in connection with construction of the DSN plant. 
The 1997 increase of $.8 million before the effect of
capitalization primarily resulted from higher average balances of
borrowed funds.

     Income Before Taxes

     The Company had income before income taxes of $1.5 million
in the second quarter of 1997 compared to income before income
taxes of $2.4 million in the three months ended June 30, 1996. 
The decreased profitability of $.9 million was primarily due to
the increases in SG&A and interest expense, partially offset by
an insurance settlement as previously discussed.

     Provision For Income Taxes

     As a result of the Company's net operating loss carryforward
for income tax purposes as discussed elsewhere herein and in Note
2 of Notes to Condensed Consolidated Financial Statements, the
Company's provisions for income taxes for the three months ended
June 30, 1997 and the three months ended June 30, 1996 are for
current state income taxes and federal alternative minimum taxes
("AMT").

Liquidity and Capital Resources

Cash Flow From Operations

     Net cash used by operations for the six months ended June
30, 1997 was $7.5 million, including adjustments for noncash
depreciation and amortization of $5.7 million, provisions for
possible losses on accounts receivable and other assets of $1.1
million, and recapture of previous years provisions for possible
losses of $1.4 million.  This net cash usage includes the
following changes in assets and liabilities:  (i) accounts
receivable increases of $5.8 million, (ii) inventory decreases of
$4.5 million, (iii) increases in supplies and prepaid items of
$.7 million, and (iv) decreases in accounts payable and accrued
liabilities of $6.9 million.  The increase in accounts receivable
is due mainly to seasonal sales increases in the Chemical
Business.  The decrease in inventories is primarily due to spring
planting season sales of fertilizer inventory that is typically
built up by the Chemical Business in the fourth quarter of each
year, in addition to an inventory reduction in the Automotive
Products Business.  The increase in supplies and prepaid items is
due primarily to increases in prepaid insurance costs and
manufacturing supplies.  The decrease in accounts payable and
accrued liabilities is due primarily to use of proceeds from the
$50 million long-term financing discussed elsewhere in this
report.

Cash Flow From Investing And Financing Activities

     Cash used by investing activities included $5.7 million in
capital expenditures (primarily in the Chemical Business) and
increased other assets of $3.0 million due primarily to (i) a
$1.0 million advance to a French manufacturer of HVAC equipment
as discussed further under "Joint Ventures and Options to
Purchase", and (ii) $1.4 million of deposits made in connection
with an interest rate hedge contract related to the 10 year
permanent financing of the nitric acid plant to be completed in
late 1998 pursuant to the agreement with Bayer.  See Note 5 of
Notes to Condensed Consolidated Financial Statements.  Net cash
provided by financing activities included (i) term borrowings of
$53.9 million, including proceeds from the new $50 million
financing discussed under "Sources of Funds", (ii) payments on
term debt of $23.0 million, including $19.1 million in
prepayments of debt with proceeds from the new $50 million
financing, (iii) decreases in revolving debt of $13.7 million,
(iv) dividends of $2.0 million, and (v) treasury stock purchases
of $.5 million.

     During the first six months of 1997, the Company  paid the
following aggregate dividends: (1) $6.00 per share on each of the
20,000 outstanding shares of its Series B 12% Cumulative
Convertible Preferred Stock; (2) $1.625 per share on each
outstanding share of its $3.25 Convertible Exchangeable Class C
Preferred Stock, Series 2; (3) $.03 per share on each outstanding
share of its Common Stock; and (4) $10.00 per share on each of
the 1,539 outstanding shares of its Redeemable Preferred Stock. 

Source of Funds  

     The Company is a diversified holding Company and its
liquidity is dependent, in large part, on the operations of its
subsidiaries and credit agreements with lenders.

     On February 13, 1997 the Company's wholly-owned
subsidiaries, El Dorado Chemical Company, Slurry Explosive
Corporation, and Northwest Financial Corporation. (collectively
"Borrowers") completed a $50 million long-term financing
agreement ("Financing") with an institutional lender. 
Approximately $19.1 million in proceeds from the Financing was
used to repay other outstanding term debt; $.2 million was used
to pay accrued interest; and, the remaining $30.7 million in
proceeds were used to pay down the Company's revolving credit
facilities and thereby create additional borrowing availability
for future working capital and other corporate needs.  The
Financing is secured by a first mortgage lien on the Chemical
Business' property, plant, and equipment located in El Dorado,
Arkansas and owned by the Borrowers, except rolling stock and
excluding the DSN Plant which is security under a separate loan
agreement.  The $50.0 million Financing consists of $25.0 million
of fixed rate notes bearing interest at 10.57% per annum and
$25.0 million of floating rate notes bearing interest at LIBOR
plus 4.2% (initially 9.76%).  Repayment of the notes is due in
quarterly installments of $833,332 plus interest commencing on
July 1, 1997 through April 2004 at which time the balance is due. 
The Financing requires the Borrowers to maintain certain
financial ratios and contains other financial covenants,
including the ratio of funded debt to total capitalization,
current ratio, and fixed charge coverage ratio, in addition to
net worth and working capital requirements.  As of the date of
this report, the Borrowers are in compliance with all financial
covenants required by the loan agreement related to the
Financing.  The Financing also contains certain restrictions on
transactions with affiliates.  The Financing limits the amount of
dividends or distributions by the Borrowers to an amount equal to
payments for federal income taxes determined as if the Borrowers
filed returns on a separate company basis and dividends up to 50%
of the Borrowers' prior year net income.  The annual interest on
the $50 million in outstanding debt under the Financing at June
30, 1997, at the rate then in effect, would approximate $5.1
million. 

     The Company and certain of its subsidiaries are parties to a
working capital line of credit evidenced by six separate loan
agreements ("Agreements") with an unrelated lender ("Lender")
collateralized by receivables, inventory, and proprietary rights
of the Company and the subsidiaries that are parties to the
Agreements and the stock of certain of the subsidiaries that are
borrowers under the Agreements.  The Agreements, as amended,
provide for revolving credit facilities ("Revolver") for total
direct borrowings up to $63.0 million, including the issuance of
letters of credit.  The Revolver provides for advances at varying
percentages of eligible inventory and trade receivables.  The
Agreements, as amended, provide for interest at the reference
rate as defined (which approximates the national prime rate) plus
1.5%, or the Eurodollar rate plus 3.875%.  At June 30, 1997 the
effective interest rate was 10%.  The annual interest on the
outstanding debt under the Revolver at June 30, 1997 at the rates
then in effect would approximate $4.3 million.  At June 30, 1997,
additional amounts that the Company could have borrowed under the
Agreements, based on eligible collateral, were approximately
$14.2 million.  Borrowings under the Revolver outstanding at June
30, 1997, were $43.4 million.  The Revolver has a scheduled
termination date of April 1, 1998, and as of June 30, 1997, the
Company was not in compliance with its financial covenants
relating to Tangible Net Worth and Debt-to-Worth.  The Company's
working capital lender has waived such defaults as of June 30,
1997.  As of the date of this report, the lender has verbally
committed to an extension of the termination date so that the
termination date will be scheduled to occur more than twelve
months from June 30, 1997, and resetting the Company's Tangible
Net Worth and Debt-to-Worth financial covenants so that such are
consistent with the Company's current projections for the next
twelve months.  Accordingly, the Company has classified the $43.4
million due  under the Revolver at June 30, 1997 as long-term
debt due after one year in the accompanying condensed
consolidated financial statements.  As of the date of this
report, there are no such assurances that the lender will extend
the scheduled termination date and reset the Tangible Net Worth
and Debt-to-Worth financial covenants and, if such financial
covenants are reset, that the Company will be able to comply with
such reset covenants.  This paragraph contains certain forward-
looking statements, including but not limited to, the reference
to projections over the next twelve months and that the lender
will extend the termination date and reset certain financial
covenants and the result thereof could differ materially from
such statements if, among other reasons, the Company is unable to
meet such projections due to material reduction in revenues or
adverse changes to the Company's businesses or the lender decides
for whatever reason not to reset the scheduled termination date
or the financial covenants.    

     In addition to the Agreements discussed above, the Company
had the following term loans in place as of June 30, 1997:

(1)  The Company s wholly-owned subsidiary, DSN Corporation
     ("DSN"), is a party to several loan agreements with a
     financing company (the  Financing Company ) for three (3)
     projects.  These loan agreements are for a $16.5 million
     term loan (the  DSN Permanent Loan"), which was used to
     construct, equip, re-erect, and refurbish the DSN Plant
     being placed into service by the Chemical Business at its El
     Dorado, Arkansas facility; a loan for approximately $1.2
     million to purchase additional railcars to support the DSN
     Plant (the  Railcar Loan ); and a loan for approximately
     $1.1 million to finance the construction of a mixed acid
     plant (the  Mixed Acid Plant ) in North Carolina (the  Mixed
     Acid Loan ).  At June 30, 1997, DSN had outstanding
     borrowings of $12.9 million under the DSN Permanent Loan,
     $.9 million under the Mixed Acid Loan, and $1.0 million
     under the Railcar Loan.  The loans have repayment schedules
     of eighty-four (84) consecutive monthly installments of
     principal and interest.  The interest rate on each of the
     loans is fixed and range from 8.24% to 8.86%.  Annual
     interest, for the three notes as a whole, at June 30, 1997
     at the agreed to interest rates would approximate $1.3
     million.  The loans are secured by the various DSN and Mixed
     Acid Plants property and equipment, and all railcars
     purchased under the Railcar Loan.  The loan agreements
     require the Company to maintain certain financial ratios, 
     including tangible net worth requirements.  As of the date
     of this report, the Company is in compliance with all
     financial covenants or if not in compliance, has obtained
     appropriate waivers from the Financing Company.

(2)  As of June 30, 1997, a subsidiary of the Company ("Prime")
     was a party to an agreement ("Agreement") with a national
     bank ("Bank").  The Agreement, as modified, requires
     interest per annum at a rate equal to three quarters of one
     percent (.75%) above the prime rate in effect from day to
     day as published in the Wall Street Journal.  The
     outstanding principal balance of the note is payable in
     sixty (60) monthly payments of principal and interest. 
     Payment of the note is secured by a first and priority lien
     and security interest in and to Prime's right, title, and
     interest in the loan receivable relating to the real
     property and office building located in Oklahoma City,
     Oklahoma (the "Tower"), and the Management Agreement
     relating to the Tower.  In February 1997, the Company
     exercised its option to purchase the Tower by  paying
     approximately $140,000 for the exercise price under the
     purchase option and related costs and accordingly $14.0
     million of carrying value was transferred to property, plant
     and equipment.

     Future cash requirements include working capital
requirements for anticipated sales increases in all Businesses,
and funding for future capital expenditures, primarily in the
Chemical Business and the Environmental Control Business. 
Funding for the higher accounts receivable resulting from
anticipated sales increases will be provided by cash flow
generated by the Company and the revolving credit facilities
discussed elsewhere in this report.  Inventory requirements for
the higher anticipated sales activity should be met by scheduled
reductions in the inventories of the Industrial Products Business
and in the inventories of the Automotive Products Business.  In
the remaining six months of 1997, the Company has planned capital
expenditures of approximately $4.1 million, primarily in the
Chemical and Environmental Control Businesses. 

     SBL Corporation ("SBL"), a corporation wholly owned by the
spouse and children of Jack E. Golsen, Chairman of the Board and
President of the Company, including, but not limited to, Barry H.
Golsen, son of Jack E. Golsen and Vice Chairman of the Board of
the Company, has proposed to the Company that it is willing to
infuse into the Company $3 million of new equity.  Under such
proposal, SBL proposes that the Company issue to SBL for such $3
million three million (3,000,000) shares of a newly created
series of preferred stock, with (i) each share of preferred stock
having one (1) vote and voting with the Common Stock of the
Company as a single class and bearing a dividend rate of 10% per
annum, with such dividends being cumulative, (ii) such preferred
stock is to be convertible into Common Stock of the Company held
by the Company as treasury shares at a conversion rate to be
negotiated , and (iii) the preferred stock containing such other
terms, rights and preferences as are standard in such series of
preferred stock.

     At the meeting of the Board of Directors on August 14, 1997,
the Board of Directors established a special committee of the
Board ("Committee") consisting of four (4) outside and
independent directors.  The Committee was given full power and
authority to evaluate the proposal for the Company, negotiate the
terms and provisions of such transaction, if any, retain legal,
financial and other advisors to assist the Committee in
performance of its duties, and, if such preferred is to be
issued, to fix and establish the terms thereof and authorize the
issuance of such preferred on terms approved by the Committee. 
The Committee was established by the Board at its meeting held on
August 14, 1997, and has not yet begun to consider or evaluate
the proposal.  There are no assurances that this transaction will
be completed, or, if completed, that the terms of such
transaction will be as set forth in the proposal by SBL.

     Management believes that cash flows from operations, the
Company's revolving credit facilities, and other sources,
including the possible infusion of $3 million of new equity
proposed to be provided by SBL discussed above, will be adequate
to meet its presently anticipated capital expenditure, working
capital, debt service, and dividend requirements.  The above
sentence and certain statements contained in the preceding
paragraph are forward-looking statements that involve a number of
risks and uncertainties that could cause actual results to differ
materially, such as, a material reduction in revenues, continuing
to incur losses, inability to collect a material amount of
receivables, required capital expenditures in excess of those
presently anticipated, or the Company is unable  to finance such
capital expenditures on terms acceptable to the Company, the
Company and SBL do not complete the transaction discussed above
for any reason, or other future events, not presently
predictable, which individually or in the aggregate could impair
the Company's ability to obtain funds to meet its requirements. 
Although the Company has planned capital expenditures, there are
no material irrevocable commitments to such at the date of this
report.  The commitment to build the nitric acid plant discussed
in Note 5 to Notes to Condensed Financial Statements is to be
financed by an unaffiliated lender.

Foreign Subsidiary Financing

     The Company has guaranteed a revolving credit working
capital facility (the "Facility") between TES and Bank of New
Zealand (the "Lender").  The Facility allows for borrowings based
on specific percentages of qualified eligible assets.  Based on
the effective exchange rate at June 30, 1997, approximately
US$4.9 million (A$7 million approximately) was borrowed at June
30, 1997.  Such debt is secured by substantially all the assets
of TES, plus an unlimited guarantee and indemnity from the
Company.  The interest rate on this debt is the Bank of New
Zealand Corporate Lending Rate plus 0.5% (approximately 9.5% at
June 30, 1997).  TES is in technical non-compliance with a
certain financial covenant contained in the loan agreement
involving the Facility.  However, this covenant was not met at
the time of closing and the Lender agreed and continues to agree
as of the date of this report that the covenant is something to
work towards in the future and has continued to allow TES to
borrow under the Facility.  The outstanding borrowing under the
Facility at June 30, 1997 has been classified as due within one
year in the accompanying Consolidated Financial Statements.

     The Lender has verbally agreed to amend the Facility to
allow for borrowings up to an aggregate of A$11 million
Australian.  This A$11 million will be broken down into three
parts: a A$6 million revolving working capital facility; a A$4.5
million long-term debt facility; and, a A$.5 million leasing
facility.

Joint Ventures and Options to Purchase

     Prior to 1997, the Company, through a subsidiary, loaned
$2.9 million to a French manufacturer of HVAC equipment whose
product line is compatible with that of the Company's
Environmental Control Business in the USA.  Under the loan
agreement, the Company has the option to exchange its rights
under the loan for 100% of the borrower's outstanding common
stock.  The Company obtained a security interest in the stock of
the French manufacturer to secure its loan.  During the first six
months of 1997 the Company advanced an additional $1 million to
the French manufacturer bringing the total of the loan at June
30, 1997 to $3.8 million. As of the date of this report, the
decision has not been made to exercise such option and the $3.8
million loan, net of a $1.5 million valuation reserve, is carried
on the books as a note receivable in other assets.  

     During 1995, the Company executed a stock option agreement
to acquire eighty percent (80%) of the stock of a specialty sales
organization ("Optioned Company") to enhance the marketing of the
Company's air conditioning products.  The stock option has a four
(4) year term, and a total option granting price of $1.0 million
and annual $100,000  payments for yearly extensions of the stock
option thereafter for up to three (3) years.  Through June 30,
1997 the Company has made option payments aggregating $1.2
million and has loaned the Optioned Company approximately
$983,000.  The Company has recorded reserves of $605,000 against
the loans and investments.  Upon exercise of the stock option by
the Company, or upon the occurrence of certain performance
criteria which would give the grantors of the stock option the
right to accelerate the date on which the Company must elect
whether to exercise, the Company shall pay certain cash and issue
promissory notes for the balance of the exercise price of the
subject shares.  The total exercise price of the subject shares
is $4.0 million, less the amounts paid for the granting and any
extensions of the stock option.  As of the date of this report,
no decision to exercise this option has been reached by the
Company.  

     In 1995, a subsidiary of the Company invested approximately
$2.8 million to purchase a fifty percent (50%) equity interest in
an energy conservation joint venture (the "Project").  The
Project had been awarded a contract to retrofit residential
housing units at a US Army base which it completed during 1996. 
The completed contract was for installation of energy-efficient
equipment (including air conditioning and heating equipment),
which would reduce utility consumption.  For the installation and
management, the Project will receive an average of seventy-seven
percent (77%) of all energy and maintenance savings during the
twenty (20) year contract term.  The Project spent approximately
$17.5 million  to retrofit the residential housing units at the
US Army base.  The Project received a loan from a lender to
finance  approximately $14.0 million of the cost of the Project. 
The Company is not guaranteeing any of the lending obligations of
the Project.  

Debt Guarantee 

     As disclosed in Note 5 of the Notes to Condensed
Consolidated Financial Statements a subsidiary of the Company and
one of its subsidiaries have guaranteed approximately $2.6
million of indebtedness of a start up aviation company in
exchange for an ownership interest.  The debt guarantee relates
to two note instruments.  One note for which the subsidiary had
guaranteed up to $600,000 had a balance of approximately
$1,051,000 as of June 30, 1997.  The other note in the amount of
$2.0 million requires monthly principal payments of $11,111 plus
interest beginning in October 1998 through August 8, 1999, at
which time all outstanding principal and accrued interest are
due.  In the event of default of the $2.0 million note, the
Company is required to assume payments on the note with the term
extended until August 2004.  Both notes are current as to
principal and interest.

     During 1996 and 1997, the aviation company received cash
infusions of $6.0 million from an unrelated third party investor
for a 41.6% ownership interest in the aviation company.  During
1997, the investor exercised an option to purchase additional
stock of the aviation company in exchange for $4.0 million in
scheduled payments.  At the date of this report, $1.0 million of
payments under this option have been received.

Availability of Company's Loss Carryovers

     The Company anticipates that its cash flow in future years
will benefit from its ability to use net operating loss ("NOL")
carryovers from prior periods to reduce the federal income tax
payments which it would otherwise be required to make with
respect to income generated in such future years; however, such
benefit will be limited by the Company's reduced NOL for
alternative minimum tax purposes which is approximately $10.0
million at December 31, 1996.  As of December 31, 1996, the
Company had available NOL carryovers of approximately $45.0
million, based on its federal income tax returns as filed with
the Internal Revenue Service for taxable years through 1995, and
on the Company's estimates for 1996.  These NOL carryovers will
expire beginning in the year 1999.

     The above paragraph contains certain forward-looking
statements.  The amount of these carryovers has not been audited
or approved by the Internal Revenue Service and, accordingly, no
assurance can be given that such carryovers will not be reduced
as a result of audits in the future.  In addition, the ability of
the Company to utilize these carryovers in the future will be
subject to a variety of limitations applicable to corporate
taxpayers generally under both the Internal Revenue Code of 1986,
as amended, and the Treasury Regulations.  These include, in
particular, limitations imposed by Code Section 382 and the
consolidated return regulations.

Contingencies

     As discussed in Note 5 of Notes to Condensed Consolidated
Financial Statements, the Company has several contingencies that
could impact its liquidity in the event that the Company is
unsuccessful in defending against the claimants.  Although
management does not anticipate that these claims will result in
substantial adverse impacts on its liquidity, it is not possible
to determine the outcome.  The preceding sentence is a forward
looking statement that involves a number of risks and
uncertainties that could cause actual results to differ
materially, such as, among other factors, the following:  the EIL
Insurance does not provide coverage to the Company and the
Chemical Business for any material claims made by the claimants,
the claimants alleged damages are not covered by the EIL Policy
which a court may find the Company and/or the Chemical Business
liable for, such as punitive damages or penalties, a court finds
the Company and/or the Chemical Business liable for damages to
such claimants for a material amount in excess of the limits of
coverage of the EIL Insurance or a court finds the Chemical
Business liable for a material amount of damages in the antitrust
lawsuits pending against the Chemical Business in a manner not
presently anticipated by the Company.


                                  PART II
                             OTHER INFORMATION



Item 1.   Legal Proceedings

     There are no additional material legal proceedings pending
against the Company and/or its subsidiaries not previously
reported by the Company in Item 3 of its Form 10-K for the fiscal
period ended December 31, 1996, which Item 3 is incorporated by
reference herein.
     
Item 2.   Changes in Securities

     Not applicable.

Item 3.   Defaults upon Senior Securities

     Not applicable.

Item 4.   Submission of Matters to a Vote of Security Holders

     At the Company's 1997 Annual Meeting of Shareholders held on
June 27, 1997, the following nominees to the Board of Directors
were elected as directors of the Company:
                                                      Number of       
                                         Shares         Number of
                                      "Against" and   Abstentions
                         Number of       to "Withhold    and Broker
     Name               Shares "For"       Authority"      Non-Votes
- --------------------   ------------      ------------   -----------
Gerald J. Gagner         10,397,346         1,402,698         -    
Barry H. Golsen          10,683,094         1,116,950         -    
David R. Goss            10,690,093         1,109,951         -    
Donald J. Munson         10,686,246         1,113,798         -    
Jerome D. Shaffer, M.D.  10,542,127         1,257,917         -    


     Messrs Golsen, Goss and Shaffer had been serving on the
Board of Directors at the time of the Annual Meeting and were
reelected for a term of three (3) years.  Mr. Gagner was not
serving as a director of the Company at the time of the Annual
Meeting and was elected for a term of one (1) year.  Mr. Munson
was not serving as a director of the Company at the time of the
Annual Meeting and was elected for a term of two (2) years.  The
following are the directors whose terms of office continued after
such Annual Meeting:  Raymond B. Ackerman, Robert C. Brown, M.D.,
Jack E. Golsen, Bernard G. Ille, Horace G. Rhodes, Jerome D.
Shaffer, M.D. and Tony M. Shelby.


     At the annual Meeting, Ernst & Young, LLP, Certified Public
Accountants, was appointed as independent auditors of the Company
for 1997, as follows:
                                         Number of 
                                          Shares                  
                                         "Against"    Number of  
                                         and to       Abstentions
                       Number of         "Withhold    and Broker 
                     Shares "For"        Authority"   Non-Votes  
                     -----------         ---------    ---------
                      11,156,349           624,316      19,379   

     At the Annual Meeting, a shareholder proposal to amend the
Corporation's by-laws to prohibit the election to the Board of
Directors of any person above the age of seventy (70) was
defeated, as follows:

                                         Number of 
                                         Shares                  
                                         "Against"    Number of  
                                         and to       Abstentions
                       Number of         "Withhold    and Broker 
                     Shares "For"        Authority"   Non-Votes  
                     -----------         ---------    ---------
                      1,990,579          6,795,013    3,014,452  


     At the Annual Meeting, a shareholder proposal recommending
that the Board of Directors consider amending the Company's
Certificate of Incorporation to adopt cumulative voting was
defeated, as follows:


                                         Number of 
                                         Shares                  
                                         "Against"    Number of  
                                         and to       Abstentions
                       Number of         "Withhold    and Broker 
                     Shares "For"        Authority"   Non-Votes  
                     -----------         ---------    ----------
                      2,988,725          5,785,237    3,026,082  

     At the Annual Meeting, a shareholder proposal recommending
that the Board of Directors consider amending the Company's
Certificate of Incorporation to eliminate the staggered terms of
the Board of Directors was defeated, as follows:


                                         Number of 
                                         Shares                  
                                         "Against"    Number of  
                                         and to       Abstentions
                       Number of         "Withhold    and Broker 
                     Shares "For"        Authority"   Non-Votes  
                     -----------         ---------    ---------
                      2,936,094          5,835,291    3,028,659  


Item 5.   Other Information

     Not applicable.

Item 6.   Exhibits and Reports on Form 8-K

     (A)  Exhibits.  The Company has included the following
          exhibits in this report:

          4.1.  Seventh Amendment to Loan and Security Agreement
          between the Company and BankAmerica Business Credit,
          Inc.  Substantially identical Seventh Amendments were
          entered into by each of L&S Bearing, International
          Environmental Corporation, Climate Master, Inc., Summit
          Machine Tool Manufacturing Corp., an El Dorado Chemical
          Company and are omitted herefrom, and such will be
          provided to the Commission upon request.  

          4.2. Eighth Amendment to Loan and Security Agreement
          between the Company and BankAmerica Business Credit,
          Inc.  Substantially identical Seventh Amendments were
          entered into by each of L&S Bearing, International
          Environmental Corporation, Climate Master, Inc., Summit
          Machine Tool Manufacturing Corp., an El Dorado Chemical
          Company and are omitted herefrom, and such will be
          provided to the Commission upon request.

          10.1 Anhydrous Ammonia Sales Agreement dated May 28,
          1997, to be effective January 1, 1997, between Koch
          Nitrogen Company and El Dorado Chemical Company. 
          CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN
          OMITTED AS IT IS THE SUBJECT OF A REQUEST BY THE
          COMPANY FOR CONFIDENTIAL TREATMENT BY THE SECURITIES
          AND EXCHANGE COMMISSION UNDER THE FREEDOM OF
          INFORMATION ACT.  THE OMITTED INFORMATION HAS BEEN
          FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES
          AND EXCHANGE COMMISSION FOR PURPOSES OF SUCH REQUEST.

          10.2 Baytown Nitric Acid Project and Supply Agreement
          dated June 27, 1997 by and among El Dorado Nitrogen
          Company, El Dorado Chemical Company and Bayer
          Corporation.  CERTAIN INFORMATION WITHIN THIS EXHIBIT
          HAS BEEN OMITTED AS IT IS THE SUBJECT OF A REQUEST BY
          THE COMPANY FOR CONFIDENTIAL TREATMENT BY THE
          SECURITIES AND EXCHANGE COMMISSION UNDER THE FREEDOM OF
          INFORMATION ACT.  THE OMITTED INFORMATION HAS BEEN
          FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES
          AND EXCHANGE COMMISSION FOR PURPOSES OF SUCH REQUEST.

          10.3 Services Agreement dated June 27, 1997, between
          Bayer Corporation and El Dorado Nitrogen Company. 
          CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN
          OMITTED AS IT IS THE SUBJECT OF A REQUEST BY THE
          COMPANY FOR CONFIDENTIAL TREATMENT BY THE SECURITIES
          AND EXCHANGE COMMISSION UNDER THE FREEDOM OF
          INFORMATION ACT.  THE OMITTED INFORMATION HAS BEEN
          FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES
          AND EXCHANGE COMMISSION FOR PURPOSES OF SUCH REQUEST. 
          Additionally, the Exhibits and Schedules to the
          Services Agreement have not been filed herewith, but
          will be filed supplementally upon request of the
          Commission, with the exception that SCHEDULE 6, WASTE,
          IS THE SUBJECT OF A REQUEST BY THE COMPANY FOR
          CONFIDENTIAL TREATMENT BY THE SECURITIES AND EXCHANGE
          COMMISSION UNDER THE FREEDOM OF INFORMATION ACT. 
          SCHEDULE 6 HAS NOT BEEN FILED AS A SCHEDULE TO THIS 10-
          Q AS SUCH ENTIRE DOCUMENT IS THE SUBJECT OF A REQUEST
          FOR CONFIDENTIAL TREATMENT, BUT SUCH DOCUMENT HAS BEEN
          FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES
          AND EXCHANGE COMMISSION FOR PURPOSES OF SUCH REQUEST.  

          10.4 Ground Lease dated June 27, 1997, between Bayer
          Corporation and El Dorado Nitrogen Company.

          10.5 Participation Agreement, dated as of June 27,
          1997, among El Dorado Nitrogen Company, Boatmen's Trust
          Company of Texas as Owner Trustee, Security Pacific
          Leasing Corporation, as Owner Participant and a
          Construction Lender, Wilmington Trust Company,
          Bayerische Landesbank, New York Branch, as a
          Construction Lender and the Note Purchaser, and Bank of
          America National Trust and Savings Association, as
          Construction Loan Agent.  The Exhibits and Schedules to
          the Participation Agreement have not been filed
          herewith, but will be filed supplementally upon request
          of the Commission, with the exception that Exhibit E,
          the Lease, and Exhibit F-1, the Ground Lease have been
          filed as separate exhibits to this Form 10-Q and
          EXHIBIT D-1, THE BAYER SUPPORT AGREEMENT, EXHIBIT D-2,
          THE BAYER AGREEMENT, EXHIBIT S-1, THE BAYTOWN NITRIC
          ACID PROJECT AND SUPPLY AGREEMENT, EXHIBIT S-2, THE
          SERVICES AGREEMENT, AND SCHEDULE 6, FIXED PRICE
          PURCHASE OPTION AMOUNT ARE THE SUBJECTS OF A REQUEST BY
          THE COMPANY FOR CONFIDENTIAL TREATMENT BY THE
          SECURITIES AND EXCHANGE COMMISSION UNDER THE FREEDOM OF
          INFORMATION ACT.  EXHIBITS D-1 AND D-2 AND SCHEDULE 6
          HAVE NOT BEEN FILED AS EXHIBITS OR SCHEDULES TO THIS
          10-Q AS SUCH ENTIRE DOCUMENTS ARE THE SUBJECT OF A
          REQUEST FOR CONFIDENTIAL TREATMENT, BUT SUCH DOCUMENTS
          HAVE BEEN FILED SEPARATELY WITH THE SECRETARY OF THE
          SECURITIES AND EXCHANGE COMMISSION FOR PURPOSES OF SUCH
          REQUEST.  EXHIBITS S-1 AND S-2 HAVE BEEN FILED WITH
          INFORMATION OMITTED WHICH HAS BEEN FILED SEPARATELY
          WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE
          COMMISSION FOR PURPOSES OF SUCH REQUEST. 

          10.6 Lease Agreement dated as of June 27, 1997, between
          Boatmen's Trust Company of Texas as Owner Trustee and
          El Dorado Nitrogen Company.

          10.7 Security Agreement and Collateral Assignment of
          Construction Documents, dated as of June 27,1997, made
          by El Dorado Nitrogen Company.

          10.8 Security Agreement and Collateral Assignment of
          Facility Documents, dated as of June 27, 1997, made by
          El Dorado Nitrogen Company and consented to by Bayer
          Corporation.

          11.1 Statement Re:  Computation of Per Share Earnings.

          27.1 Financial Data Schedule.

     (B)  Reports on Form 8-K.  The Company did not file any
     reports on Form 8-K during the Quarter ended June 30, 1997.


          

                                SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of
1934, as amended, the Company has caused the undersigned, duly-
authorized, to sign this report on its behalf on this 19th day of
August, 1997.


               LSB INDUSTRIES, INC.



                            By: /s/ Tony M. Shelby              

                                Tony M. Shelby, 
                                Senior Vice President of Finance    
                                (Principal Financial Officer) 
                                

                            By: /s/ Jim D. Jones                           
                                
                                Jim D. Jones,
                                Vice President, Controller and 
                                Treasurer(Principal Accounting                 
                                Officer)